A ZnO(10 (1) over bar0) single crystal was investigated using in situ scanning tunneling microscopy and X-ray photoelectron spectroscopy. In roughly 1 mbar water the surface roughens within minutes... Show moreA ZnO(10 (1) over bar0) single crystal was investigated using in situ scanning tunneling microscopy and X-ray photoelectron spectroscopy. In roughly 1 mbar water the surface roughens within minutes. Hereby, the formation of (0001)- or (000 (1) over bar)-type steps is favored over the formation of (1 (2) over bar 10)-type steps. The roughened surface is stable in ultra-high vacuum and does not exhibit a different amount of hydroxylation or adsorbed water compared to the as-prepared surface. The speed of the roughening is related to the total volume of water supplied to the surface rather than the water pressure. Show less
In surface science there is great effort to move from studying simple, flat model surfaces in vacuum to investigating more complex model catalysts in gas environments (in situ). This thesis gives... Show moreIn surface science there is great effort to move from studying simple, flat model surfaces in vacuum to investigating more complex model catalysts in gas environments (in situ). This thesis gives three examples of such studies using microscopy and spectroscopy.Exposure of ZnO(10-10) to moderate pressures of water in an in situ scanning tunneling microscope reveals that the surface roughens. The flat ZnO(10-10) is thus only conditionally suited as a model catalyst for reactions involving water.In the same microscope, surface gold oxide formation is observed on TiO2/Au(111) during CO oxidation at 1 bar pressure. Comparisons to the Au(111) surface suggest that the titania does not supply atomic oxygen to the Au(111) substrate as part of the reaction mechanism of the CO oxidation.Co(0001) is investigated as a model catalyst for Fischer-Tropsch synthesis, the reaction of CO and H2 to form hydrocarbons. In this thesis the oxidation behavior of the cobalt and the adsorption of carbon species during the reaction are investigated using near-ambient pressure X-ray photoelectron spectroscopy.Generally, this thesis exemplifies the significant influence that small concentrations of contaminants in gases and materials can have on the structure and behavior of surfaces in in situ studies. Show less
George, L.; Taylor, A.R.; Esteve-Codina, A.; Artigas, M.S.; Thun, G.A.; Bates, S.; ... ; EvA Study Team 2020
Background: Whether the clinical or pathophysiologic significance of the "treatable trait" high blood eosinophil count in COPD is the same as for asthma remains controversial. We sought to... Show moreBackground: Whether the clinical or pathophysiologic significance of the "treatable trait" high blood eosinophil count in COPD is the same as for asthma remains controversial. We sought to determine the relationship between the blood eosinophil count, clinical characteristics and gene expression from bronchial brushings in COPD and asthma.Methods: Subjects were recruited into a COPD (emphysema versus airway disease [EvA]) or asthma cohort (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes, U-BIOPRED). We determined gene expression using RNAseq in EvA (n = 283) and Affymetrix microarrays in U-BIOPRED (n = 85). We ran linear regression analysis of the bronchial brushings transcriptional signal versus blood eosinophil counts as well as differential expression using a blood eosinophil > 200 cells/mu L as a cut-off. The false discovery rate was controlled at 1% (with continuous values) and 5% (with dichotomized values).Results: There were no differences in age, gender, lung function, exercise capacity and quantitative computed tomography between eosinophilic versus noneosinophilic COPD cases. Total serum IgE was increased in eosinophilic asthma and COPD. In EvA, there were 12 genes with a statistically significant positive association with the linear blood eosinophil count, whereas in U-BIOPRED, 1197 genes showed significant associations (266 positive and 931 negative). The transcriptome showed little overlap between genes and pathways associated with blood eosinophil counts in asthma versus COPD. Only CST1 was common to eosinophilic asthma and COPD and was replicated in independent cohorts.Conclusion: Despite shared "treatable traits" between asthma and COPD, the molecular mechanisms underlying these clinical entities are predominately different. Show less
Asthma is a global health problem affecting around 300 million individuals of all ages, ethnic groups and countries. It is estimated that around 250,000 people die prematurely each year as a result... Show moreAsthma is a global health problem affecting around 300 million individuals of all ages, ethnic groups and countries. It is estimated that around 250,000 people die prematurely each year as a result of asthma. Concepts of asthma severity and control are important in evaluating patients and their response to treatment, as well as for public health, registries, and research (clinical trials, epidemiologic, genetic, and mechanistic studies), but the terminology applied is not standardized, and terms are often used interchangeably. A common international approach is favored to define severe asthma, uncontrolled asthma, and when the 2 coincide, although adaptation may be required in accordance with local conditions. A World Health Organization meeting was convened April 5-6, 2009, to propose a uniform definition of severe asthma. An article was written by a group of experts and reviewed by the Global Alliance against Chronic Respiratory Diseases review group. Severe asthma is defined by the level of current clinical control and risks as "Uncontrolled asthma which can result in risk of frequent severe exacerbations (or death) and/or adverse reactions to medications and/or chronic morbidity (including impaired lung function or reduced lung growth in children)." Severe asthma includes 3 groups, each carrying different public health messages and challenges: (1) untreated severe asthma, (2) difficult-to-treat severe asthma, and (3) treatment-resistant severe asthma. The last group includes asthma for which control is not achieved despite the highest level of recommended treatment and asthma for which control can be maintained only with the highest level of recommended treatment. (J Allergy Clin Immunol 2010; 126: 926-38.) Show less
